This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Celldex Therapeutics Limited. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Hua Gao
Introduction
Hua Gao is a prominent inventor based in Farmington Hills, MI (US). She has made significant strides in the field of ophthalmology, particularly in the treatment of age-related macular degeneration (AMD). Her innovative approach has the potential to change the lives of many individuals suffering from eye diseases.
Latest Patents
Hua Gao holds a patent for a method of treating diseases or disorders of the eye involving undesired neovascularization. This method utilizes a complement inhibitory protein, specifically soluble complement receptor type I (sCR1). The invention focuses on the direct treatment of macular degeneration by administering this protein either intraocularly or systemically. She has 1 patent to her name.
Career Highlights
Hua Gao is associated with Celldex Therapeutics Limited, where she continues to develop her groundbreaking work. Her contributions to the field of eye treatment are noteworthy and reflect her dedication to improving patient outcomes.
Collaborations
Hua has collaborated with esteemed colleagues, including Henry C Marsh and Lawrence J Thomas, to advance her research and innovations in ophthalmology.
Conclusion
Hua Gao's work in treating age-related macular degeneration showcases her innovative spirit and commitment to medical advancements. Her contributions are paving the way for new treatment options in the field of eye care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile